HSBC Mutual Fund launches RedHex Hybrid Long-Short Fund (SIF)

▴ HSBC Mutual Fund launches RedHex Hybrid Long-Short Fund (SIF)
NFO period: 2–16 June 2026 | Minimum application: ₹10,00,000 (₹1,00,000 for Accredited Investors) .
Mumbai, June 02, 2026: HSBC Mutual Fund has launched RedHex Hybrid Long-Short Fund, a Specialised Investment Fund (SIF) strategy designed for investors seeking regular returns and capital appreciation. The strategy combines investments across asset classes - fixed income, equity arbitrage, REIT and INVIT units to pursue risk adjusted returns across market cycles. The New Fund Offer (NFO) will be open from 2 June 2026 to 16 June 2026.
SIFs were introduced to bridge the gap between traditional mutual funds and higher-ticket products like Portfolio Management Services (PMS) and Alternative Investment Funds (AIFs). RedHex Hybrid Long-Short Fund offers an intermediate investment that combines the regulatory transparency of mutual funds with portfolio flexibility.
The product is suited for ‘mid-ticket’ investors, with a minimum application of ₹10,00,000 (₹1,00,000 for Accredited Investors).
Benchmark: NIFTY 50 Hybrid Composite Debt 50:50 Index
Kailash Kulkarni, CEO, HSBC Mutual Fund, said, “Investors today are more aware and require unique solutions that are professionally managed, and built to navigate complex market conditions. RedHex Hybrid Long-Short Fund is designed as a practical middle ground - offering the clarity investors expect from mutual funds, with added flexibility of a product which is designed to be less volatile while giving superior, tax efficient risk adjusted returns.
Shriram Ramanathan, CIO Fixed Income, HSBC Mutual Fund, said, “Our focus is on robust credit selection and risk controls, aiming to deliver high accrual potential with lower volatility across market cycles. In a measured way, the fund also aims to take exposure to REITs and INVITs, both of which are growing asset classes”
The fund strategy aims to deliver strong accrual potential with relatively low volatility through a diversified allocation across asset classes designed to generate regular income with limited sensitivity to market swings, while also enhancing tax efficiency and risk-adjusted returns. Structured as an interval investment fund, it allows subscriptions on any business day and offers weekly redemptions. Underpinning all this is robust risk management, combining active portfolio management with strict strategy-level risk controls to help reduce volatility.
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026